Inhalable Curcumin is an Efficacious Treatment Strategy for Herpes Simplex Virus Type 1-Induced Neuropathology
Faculty of Health and Nutrition, Shubun University, Aichi, Japan
*Corresponding author: Isamu Mori, Professor, Faculty of Health and Nutrition, Shubun University, Aichi 491-0938, Japan, Tel: +81-586-45-2101, Fax: +81-586-45-4410, E-mail: firstname.lastname@example.org
Int J Neurol Neurother, IJNN-3-036, (Volume 3, Issue 1), Hypothesis; ISSN: 2378-3001
Received: December 21, 2015 | Accepted: January 05, 2016 | Published: January 07, 2016
Citation: Mori I (2016) Inhalable Curcumin is an Efficacious Treatment Strategy for Herpes Simplex Virus Type 1-Induced Neuropathology. Int J Neurol Neurother 2:036. 10.23937/2378-3001/3/1/1036
Copyright: © 2016 Mori I. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Curcumin, Olfactory neuron, Herpes simplex virus, Herpes simplex encephalitis, Alzheimer's disease
Turmeric, which is derived from the root of the Curcuma longa plant, is one of the most widely used spices worldwide. Scientists from various disciplines have long studied the medicinal benefits of a polyphenol extract from Curcuma longa, curcumin.It has been shown to have a broad spectrum of pharmacological activities in cancer, inflammation, and Alzheimer's disease (AD) . In an epidemiological study, continuous curcumin intake improved cognitive function in aged individuals . Interestingly, curcumin inhibited the formation of amyloid-βfibrils in vitro as well as in vivo . Furthermore, curcumin exhibits a variety of anti-microbial activities . Curcumin has been shown to suppress herpes simplex virus type-1 (HSV-1) replication in Vero cells  by inhibiting the recruitment of RNA polymerase II to the promoter regions of HSV-1 immediate-early genes . Despite its potential therapeutic efficacy, the clinical use of curcumin is restricted because of its poor aqueous solubility and relatively low penetration efficiency across the blood-brain barrier .
In a recent report, intranasal administration of the aerosolized curcumin derivative, FMeC1, efficiently targeted the frontotemporal cortex and hippocampus of 5XFAD transgenic mice with accelerated accumulation of amyloid-β . FMeC1 was possibly transported from the nasal mucosa into specific regions of the brain via the olfactory conduit [7,8]. First, nerve terminals of olfactory receptor neurons are directly exposed to the external environment in the nasal cavity. Second, these neurons take up exogenous substances and use anterograde transport for trafficking into the limbic system. Third, the olfactory system is directly connected to the frontal cortex without thalamic relay. Intriguingly, similar to epithelial cells, but unlike other neurons, olfactory neurons undergo apoptosis and neurogenesis as part of a normal turnover process that continues throughout life . Furthermore, neuronal stem cells in the subventricular zone of the adult brain predominantly migrate into the olfactory bulb, where they repair damaged olfactory neuronal circuits caused by toxic and infectious agents .
HSV-1 frequently uses the olfactory pathway to silently invade the human brain, where it targets the frontotemporal cortex and some limbic structures, such as the hippocampus [7,8]. It is conceivable that herpes simplex encephalitis (HSE) in children occurs during the course of primary HSV-1 infection, whereas in adults HSE arises from the reactivation of the latent virus in the brain [7,8]. It should also be noted that the reactivation of HSV-1 in the brain is a potent risk factor for the development of AD . Reactivated HSV-1 has been linked to an increased formation and accumulation of amyloid-β and abnormally phosphorylated tau. In addition, HSV-1-mediated disruption of autophagy in neurons also contributed to the accumulation of these abnormal proteins . Additionally, upon HSV-1 reactivation, amyloid-β may be overproduced to exert its anti-HSV-1 activity, leading to amyloid plaque formation . Thus anti-herpesviral action of curcumin is expected to limit the development of HSV-1-associated AD .
There is remarkable similarity in trafficking of inhaled curcumin and HSV-1 along the olfactory route. Therefore, I hypothesize that inhalable curcumin, in combination with standard anti-herpesviral drugs, will prevent and cure the HSV-1-induced neuropathology that is often associated with HSE and AD.
Lee WH, Loo CY, Bebawy M, Luk F, Mason RS, et al. (2013) Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century. Curr Neuropharmacol 11: 338-378.
Ng TP, Chiam PC, Lee T, Chua HC, Lim L, et al. (2006) Curry consumption and cognitive function in the elderly. Am J Epidemiol 164: 898-906.
Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, et al. (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280: 5892-5901.
Zandi K, Ramedani E, Mohammadi K, Tajbakhsh S, Deilami I, et al. (2010) Evaluation of antiviral activities of curcumin derivatives against HSV-1 in Vero cell line. Nat Prod Commun 5: 1935-1938.
Kutluay SB, Doroghazi J, Roemer ME, Triezenberg SJ (2008) Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity. Virology 373: 239-247.
McClure R, Yanagisawa D, Stec D, Abdollahian D, Koktysh D, et al. (2015) Inhalable curcumin: offering the potential for translation to imaging and treatment of Alzheimer's disease. J Alzheimers Dis 44: 283-295.
Mori I, Nishiyama Y, Yokochi T, Kimura Y (2005) Olfactory transmission of neurotropic viruses. J Neurovirol 11: 129-137.
Mori I (2015) Transolfactory neuroinvasion by viruses threatens the human brain. Acta Virol 59: 338-349.
Itzhaki RF (2014) Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus. Front Aging Neurosci 6: 202.
Mori I (2010) Herpes simplex virus type 1 persists in the aged brain through hypothetical expression of accessory genes. J Neurovirol 16: 203-207.
Bourgade K, Garneau H, Giroux G, Le Page AY, Bocti C, et al. (2015). β-amyloid peptides display protective activity against the human Alzheimer's disease-associated herpes simplex virus-1. Biogerontology 16: 85-98.
Mori I (2015) Anti-herpesviral activity of curcumin may attenuate the development of Alzheimer's disease. Med Hypotheses 84: 603.